Xcopri and Hoarseness or changing voice - a phase IV clinical study of FDA data

Summary:

Hoarseness or changing voice is found among people who take Xcopri, especially for people who are female, .

The phase IV clinical study analyzes which people take Xcopri and have Hoarseness or changing voice. It is created by eHealthMe based on reports of 2,956 people who have side effects when taking Xcopri from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 18, 2023

2,956 people reported to have side effects when taking Xcopri.
Among them, 10 people (0.34%) have Hoarseness or changing voice.

What is Xcopri?

Xcopri has active ingredients of cenobamate. eHealthMe is studying from 2,328 Xcopri users for its effectiveness, alternative drugs and more.

What is Hoarseness or changing voice?

Hoarseness or changing voice is found to be associated with 3,092 drugs and 2,560 conditions by eHealthMe.

Number of Xcopri and Hoarseness or changing voice reports submitted per year:

Could Xcopri cause Hoarseness or changing voice?

Gender of people who have Hoarseness or changing voice when taking Xcopri *:

female: 100 %
male: 0.0 %

Common drugs people take besides Xcopri *:

Common side effects people have besides Hoarseness or changing voice *:

Oropharyngeal Discomfort (pain or irritation of oropharynx): 3 people, 30.00%
Drowsiness: 3 people, 30.00%
Stress And Anxiety: 3 people, 30.00%
Flatulence (flatus expelled through the anus): 3 people, 30.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 30.00%
Aptyalism (deficiency or absence of saliva): 3 people, 30.00%
Swallowing Difficulty: 3 people, 30.00%
Headache (pain in head): 3 people, 30.00%
Productive Cough: 3 people, 30.00%
Panic Disorder: 3 people, 30.00%

Common conditions people have *:

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 60.00%
High Blood Pressure: 3 people, 30.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 20.00%
Fatigue (feeling of tiredness): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Xcopri and have Hoarseness or changing voice?

Check whether Hoarseness or changing voice is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hoarseness or changing voice and when was it recovered:

Hoarseness or changing voice in Xcopri

Expand to all the drugs that have ingredients of cenobamate:

Hoarseness or changing voice and drugs with ingredients of cenobamate

Alternative drugs to, pros and cons of Xcopri:

Xcopri (2,328 reports)

Common Xcopri side effects:

Fatigue (feeling of tiredness): 397 reports
Dizziness: 287 reports
Headache (pain in head): 200 reports
Memory loss: 108 reports

Browse all side effects of Xcopri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hoarseness or changing voice treatments and more:

Hoarseness or changing voice (62,554 reports)

COVID vaccines that are related to Hoarseness or changing voice:

Common drugs associated with Hoarseness or changing voice:

How the study uses the data?

The study uses data from the FDA. It is based on cenobamate (the active ingredients of Xcopri) and Xcopri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.